Akums Q2 FY27 Profit Jumps 168% as CDMO Revenue Rises 39%
Akums Q2 FY27 profit rose 168% to ₹115 crore as revenue grew 31.9% to ₹1,342 crore and its CDMO business, now 83% of sales, grew 38.6%.
AKUMS
Akums Launches DCGI-Approved Lasmiditan Dispersible Tablets for Acute Migraine
Akums Drugs & Pharmaceuticals Ltd. has announced the launch of Lasmiditan dispersible tablets, approved by the DCGI, for the acute […]
Akums Conducts Skill and Rehabilitation Support Program for Acid Attack Survivors
Under its Corporate Social Responsibility initiative Akums organised a three-day skill development camp at its manufacturing unit in Haridwar in […]
Akums and Tamil Nadu Agricultural University Forge Strategic Partnership to Pioneer Sustainable Pharma Innovation
In a notable move that underscores the growing convergence between agricultural science and pharmaceutical innovation, Akums Drugs and Pharmaceuticals has […]
Akums Strengthens Commitment to Healthcare Sustainability with Rooftop Solar Power
Akums Drugs & Pharmaceuticals Limited, a frontrunner in India’s pharmaceutical manufacturing sector, is taking a significant leap towards sustainability with […]
